KNOWLES CORP (KN)

US49926D1090 - Common Stock

19.4  -0.14 (-0.72%)

After market: 19.403 +0 (+0.02%)

Fundamental Rating

4

Overall KN gets a fundamental rating of 4 out of 10. We evaluated KN against 126 industry peers in the Electronic Equipment, Instruments & Components industry. KN has an average financial health and profitability rating. KN has a valuation in line with the averages, but it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

KN had positive earnings in the past year.
KN had a positive operating cash flow in the past year.
KN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years KN had a positive operating cash flow.

1.2 Ratios

KN has a Return On Assets of -17.62%. This is in the lower half of the industry: KN underperforms 72.80% of its industry peers.
The Return On Equity of KN (-26.55%) is worse than 72.00% of its industry peers.
The Return On Invested Capital of KN (4.83%) is better than 64.80% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KN is below the industry average of 8.74%.
Industry RankSector Rank
ROA -17.62%
ROE -26.55%
ROIC 4.83%
ROA(3y)-7.56%
ROA(5y)-3.87%
ROE(3y)-8.67%
ROE(5y)-4.34%
ROIC(3y)5.28%
ROIC(5y)4.66%

1.3 Margins

In the last couple of years the Profit Margin of KN has grown nicely.
KN has a better Operating Margin (7.33%) than 75.20% of its industry peers.
In the last couple of years the Operating Margin of KN has declined.
KN has a Gross Margin of 39.48%. This is in the better half of the industry: KN outperforms 68.80% of its industry peers.
KN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.33%
PM (TTM) N/A
GM 39.48%
OM growth 3Y-1.61%
OM growth 5Y-8.73%
PM growth 3Y127.98%
PM growth 5Y4.56%
GM growth 3Y2.43%
GM growth 5Y-0.31%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KN is destroying value.
Compared to 1 year ago, KN has less shares outstanding
KN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for KN is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.99 indicates that KN is not in any danger for bankruptcy at the moment.
KN's Altman-Z score of 2.99 is in line compared to the rest of the industry. KN outperforms 48.00% of its industry peers.
The Debt to FCF ratio of KN is 1.61, which is an excellent value as it means it would take KN, only 1.61 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.61, KN is in the better half of the industry, outperforming 77.60% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that KN is not too dependend on debt financing.
The Debt to Equity ratio of KN (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.61
Altman-Z 2.99
ROIC/WACC0.47
WACC10.21%

2.3 Liquidity

A Current Ratio of 2.35 indicates that KN has no problem at all paying its short term obligations.
KN has a Current ratio (2.35) which is in line with its industry peers.
KN has a Quick Ratio of 1.67. This is a normal value and indicates that KN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.67, KN perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.67

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.52% over the past year.
KN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.75% yearly.
The Revenue has grown by 19.30% in the past year. This is quite good.
KN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.07% yearly.
EPS 1Y (TTM)6.52%
EPS 3Y10.78%
EPS 5Y-2.75%
EPS Q2Q%-16.13%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y-2.54%
Revenue growth 5Y-3.07%
Sales Q2Q%-18.62%

3.2 Future

KN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.49% yearly.
The Revenue is expected to decrease by -4.23% on average over the next years.
EPS Next Y16.32%
EPS Next 2Y14.12%
EPS Next 3Y17.49%
EPS Next 5YN/A
Revenue Next Year-2.55%
Revenue Next 2Y-9.19%
Revenue Next 3Y-4.23%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.80 indicates a rather expensive valuation of KN.
Based on the Price/Earnings ratio, KN is valued a bit cheaper than the industry average as 78.40% of the companies are valued more expensively.
KN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
KN is valuated rather expensively with a Price/Forward Earnings ratio of 17.12.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KN indicates a somewhat cheap valuation: KN is cheaper than 79.20% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. KN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.8
Fwd PE 17.12

4.2 Price Multiples

67.20% of the companies in the same industry are more expensive than KN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KN indicates a rather cheap valuation: KN is cheaper than 88.80% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.23
EV/EBITDA 16.3

4.3 Compensation for Growth

KN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as KN's earnings are expected to grow with 17.49% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y14.12%
EPS Next 3Y17.49%

0

5. Dividend

5.1 Amount

No dividends for KN!.
Industry RankSector Rank
Dividend Yield N/A

KNOWLES CORP

NYSE:KN (12/20/2024, 8:21:22 PM)

After market: 19.403 +0 (+0.02%)

19.4

-0.14 (-0.72%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-24 2024-10-24/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners100.7%
Inst Owner Change3.35%
Ins Owners3.19%
Ins Owner Change0.18%
Market Cap1.71B
Analysts83.33
Price Target22.19 (14.38%)
Short Float %3.02%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.28%
Min EPS beat(2)-2.91%
Max EPS beat(2)-1.65%
EPS beat(4)1
Avg EPS beat(4)-1.14%
Min EPS beat(4)-7.85%
Max EPS beat(4)7.87%
EPS beat(8)4
Avg EPS beat(8)1.47%
EPS beat(12)8
Avg EPS beat(12)4.66%
EPS beat(16)11
Avg EPS beat(16)5.81%
Revenue beat(2)0
Avg Revenue beat(2)-7.98%
Min Revenue beat(2)-13.25%
Max Revenue beat(2)-2.71%
Revenue beat(4)0
Avg Revenue beat(4)-5.3%
Min Revenue beat(4)-13.25%
Max Revenue beat(4)-2.33%
Revenue beat(8)0
Avg Revenue beat(8)-5.09%
Revenue beat(12)0
Avg Revenue beat(12)-4.73%
Revenue beat(16)0
Avg Revenue beat(16)-4%
PT rev (1m)-1.14%
PT rev (3m)4.82%
EPS NQ rev (1m)-6.67%
EPS NQ rev (3m)-25.33%
EPS NY rev (1m)-2.96%
EPS NY rev (3m)-12.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.93%
Valuation
Industry RankSector Rank
PE 19.8
Fwd PE 17.12
P/S 2.08
P/FCF 12.23
P/OCF 10.99
P/B 2.2
P/tB 4.96
EV/EBITDA 16.3
EPS(TTM)0.98
EY5.05%
EPS(NY)1.13
Fwd EY5.84%
FCF(TTM)1.59
FCFY8.18%
OCF(TTM)1.76
OCFY9.1%
SpS9.34
BVpS8.83
TBVpS3.91
PEG (NY)1.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.62%
ROE -26.55%
ROCE 6.12%
ROIC 4.83%
ROICexc 5.34%
ROICexgc 10.35%
OM 7.33%
PM (TTM) N/A
GM 39.48%
FCFM 16.98%
ROA(3y)-7.56%
ROA(5y)-3.87%
ROE(3y)-8.67%
ROE(5y)-4.34%
ROIC(3y)5.28%
ROIC(5y)4.66%
ROICexc(3y)5.55%
ROICexc(5y)4.94%
ROICexgc(3y)14.66%
ROICexgc(5y)15.56%
ROCE(3y)6.68%
ROCE(5y)5.89%
ROICexcg growth 3Y-25.98%
ROICexcg growth 5Y-15.25%
ROICexc growth 3Y-4.13%
ROICexc growth 5Y-9.82%
OM growth 3Y-1.61%
OM growth 5Y-8.73%
PM growth 3Y127.98%
PM growth 5Y4.56%
GM growth 3Y2.43%
GM growth 5Y-0.31%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.61
Debt/EBITDA 1.54
Cap/Depr 29.4%
Cap/Sales 1.91%
Interest Coverage 4.9
Cash Conversion 136.68%
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 1.67
Altman-Z 2.99
F-Score4
WACC10.21%
ROIC/WACC0.47
Cap/Depr(3y)58.1%
Cap/Depr(5y)60.54%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.52%
EPS 3Y10.78%
EPS 5Y-2.75%
EPS Q2Q%-16.13%
EPS Next Y16.32%
EPS Next 2Y14.12%
EPS Next 3Y17.49%
EPS Next 5YN/A
Revenue 1Y (TTM)19.3%
Revenue growth 3Y-2.54%
Revenue growth 5Y-3.07%
Sales Q2Q%-18.62%
Revenue Next Year-2.55%
Revenue Next 2Y-9.19%
Revenue Next 3Y-4.23%
Revenue Next 5YN/A
EBIT growth 1Y5.42%
EBIT growth 3Y-4.1%
EBIT growth 5Y-11.53%
EBIT Next Year30.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y133.22%
FCF growth 3Y3.12%
FCF growth 5Y41.8%
OCF growth 1Y48%
OCF growth 3Y-1.43%
OCF growth 5Y4.49%